Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Saxagliptin Market: By Dosage: 2.5 mg, 5 mg, Others; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Saxagliptin Market Outlook
The global saxagliptin market is expected to grow at a CAGR of 4% in the forecast period of 2022-2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Asia Pacific Region to Witness a Robust Growth in the Saxagliptin Industry, Owing to Rising Government Funding
The market for saxagliptin is being driven by the rising cases of diabetes across the globe. North America and Europe are the significant markets for saxagliptin globally. This is attributed to a large number of ageing population and the rising prevalence of type II diabetes. The Asia Pacific region is expected to witness a robust growth rate in the forecast period. Countries, especially China and India, are predicted to exhibit a high growth rate of the saxagliptin industry in the Asia Pacific region. Factors such as increasing healthcare expenditure, a large pool of patients, and rising government funding are contributing to the market growth of saxagliptin in the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Saxagliptin: Industry Definition and Segmentation
Saxagliptin is the medicine used to treat diabetes. It works by boosting the level of insulin in the body produced after the meal. The product is marketed under the brand name called Onglyza. Saxagliptin acts on a natural hormone in the body, which is called incretins. The product has various side effects such as urinary tract infection, headache, upper respiratory tract infection, and nasopharyngitis. Saxagliptin can also cause complications like stroke and heart attack.
On the basis of dosage, the market is divided into:
- 2.5 mg
- 5 mg
- Others
Based on distribution channel, the industry can be segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Incidences of Type II Diabetes to Aid the Global Market Growth of Saxagliptin
The market for saxagliptin is being driven by the rising incidences of type II diabetes across the globe. The market drivers, such as increased sedentary lifestyle, rising prevalence of obesity, increased government funding, and junk food habits, are contributing to the market growth of saxagliptin. Further, the rising healthcare awareness is expected to fuel the market growth over the forecast period. The market is expanding due to further innovations taking place in the saxagliptin industry. This is further expected to aid the market growth over the forecast period. However, the market is expected to witness a setback owing to the factors, such as stringent regulations for the approval of drugs and the availability of substitutes for the treatment of diabetes.
Key Industry Players in the Global Saxagliptin Market
The report gives a detailed analysis of the following key players in the global saxagliptin market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- AstraZeneca plc.
- Wellona Pharma
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Dosage, Distribution Channel, Region |
| Breakup by Dosage | 2.5 mg, 5 mg, Others |
| Breakup by Distribution Channel | Hospital Pharmacy, Retail Pharmacy, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | AstraZeneca plc., Wellona Pharma, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Saxagliptin Market Analysis
8.1 Key Industry Highlights
8.2 Global Saxagliptin Historical Market (2017-2021)
8.3 Global Saxagliptin Market Forecast (2022-2027)
8.4 Global Saxagliptin Market by Dosage
8.4.1 2.5 mg
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 5 mg
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Others
8.5 Global Saxagliptin Market by Distribution Channel
8.5.1 Hospital Pharmacy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Retail Pharmacy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Others
8.6 Global Saxagliptin Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles (*This list is only indicative. The report contains a more comprehensive list of players.)
12.2.1 AstraZeneca plc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Wellona Pharma
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Saxagliptin Market: Key Industry Highlights, 2016 and 2026
2. Global Saxagliptin Historical Market: Breakup by Dosage (USD Million), 2017-2021
3. Global Saxagliptin Market Forecast: Breakup by Dosage (USD Million), 2022-2027
4. Global Saxagliptin Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
5. Global Saxagliptin Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
6. Global Saxagliptin Historical Market: Breakup by Region (USD Million), 2017-2021
7. Global Saxagliptin Market Forecast: Breakup by Region (USD Million), 2022-2027
8. North America Saxagliptin Historical Market: Breakup by Country (USD Million), 2017-2021
9. North America Saxagliptin Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Europe Saxagliptin Historical Market: Breakup by Country (USD Million), 2017-2021
11. Europe Saxagliptin Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Asia Pacific Saxagliptin Historical Market: Breakup by Country (USD Million), 2017-2021
13. Asia Pacific Saxagliptin Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Latin America Saxagliptin Historical Market: Breakup by Country (USD Million), 2017-2021
15. Latin America Saxagliptin Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Middle East and Africa Saxagliptin Historical Market: Breakup by Country (USD Million), 2017-2021
17. Middle East and Africa Saxagliptin Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Global Saxagliptin Market Structure
Key Questions Answered in the Report
The global saxagliptin market is projected to grow at a CAGR of 4% between 2021 and 2026.
The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of diabetes, a growing number of ageing population, rising healthcare expenditure, large pool of patients, increasingly sedentary lifestyle, and growing prevalence of obesity, are expected to aid the market growth.
The key trends guiding the growth of the market include the rising innovations and increasing government funding.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading dosages of saxagliptin in the market are 2.5 mg and 5 mg, among others.
The major distribution channels in the industry are hospital pharmacy and retail pharmacy, among others.
The major players in the industry are AstraZeneca plc. and Wellona Pharma, among others.
Analyst Review
The global saxagliptin market is being driven by the rising prevalence of diabetes. Aided by the rising innovations in the industry, the market is expected to witness a moderate growth in the forecast period of 2022-2027, growing at a CAGR of 4%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on dosage, the market is segmented into 2.5 mg and 5 mg, among others. On the basis of distribution channel, the industry is divided into hospital pharmacy and retail pharmacy, among others. The major regional markets for saxagliptin are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AstraZeneca plc. and Wellona Pharma, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global liposomal doxorubicin market attained a value of more than USD 1,100 million in 2021, driven by the increase in breast and ovarian cancer cases, as well as increased awareness of the advant...
The global peptide therapeutics market attained a value of 31.4 billion in 2021, driven by the increasing prevalence of cancer. Aided by the increasing clinical trials and the growing FDA approval of ...
The global infertility drugs market is being driven by the rising cases of infertility among men and women. Aided by the rising investments to develop advanced infertility treatment laboratories, the ...
The global contraceptive drugs market attained a value of nearly USD 16.37 billion in 2021, driven by the increasing availability of free and subsidised contraceptive drugs. Aided by the rising accept...
The global influenza vaccine market attained a value of nearly USD 5.1 billion in 2020, driven by the rising awareness regarding the importance of influenza vaccines. Aided by advancements in vaccines...
NEWSLETTER